A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.

Metformin - a drug commonly used to treat diabetes, prevents the development of long COVID, a new study published in The Lancet Infectious Diseases, University of Minnesota has found. According to the research – called COVID-OUT,

One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.